These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection. Agha Abbaslou M; Karbasi M; Mozhdehipanah H Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316 [TBL] [Abstract][Full Text] [Related]
4. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Tutar NK; Eyigürbüz T; Yildirim Z; Kale N Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408 [TBL] [Abstract][Full Text] [Related]
5. Concomitant Guillain-Barré syndrome and cerebral venous thrombosis complicating a SARS-CoV-2 infection: a case report. Qorchi H; Kissani N; Chraa M Pan Afr Med J; 2022; 42():212. PubMed ID: 36845246 [TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report. Ramirez N; Ujueta D; Diaz LF; Folleco LE; Rodríguez A; Gaona I; Nava-Mesa MO J Med Case Rep; 2021 Nov; 15(1):558. PubMed ID: 34782002 [TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré Syndrome Associated with SARS CoV-2 Infection: Case Report. Nigatu D; Tigabu T; Awraris M; Yohannes A; Kebede D Ethiop J Health Sci; 2022 Jan; 32(1):205-208. PubMed ID: 35250231 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology? Guilmot A; Maldonado Slootjes S; Bissay V; Dubuisson N; de Broglie C; Gille M Acta Neurol Belg; 2022 Jun; 122(3):703-707. PubMed ID: 34476752 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome. Finsterer J; Matovu D; Scorza FA Clinics (Sao Paulo); 2022; 77():100064. PubMed ID: 35751951 [TBL] [Abstract][Full Text] [Related]
10. The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit. Diaz P; Leveque M; Hautecloque G; Sellal F; Augereau O; Lita L; Biegle E; Belilita L; Bouterra C; Rerat P; Alvarez-Gonzalez A; Martinot M; Gerber V J Neuroimmunol; 2022 May; 366():577842. PubMed ID: 35339941 [TBL] [Abstract][Full Text] [Related]
11. The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation. Biassoni E; Assini A; Gandoglia I; Benedetti L; Boni S; Pontali E; Feasi M; Gandolfo F; Del Sette M J Neurovirol; 2021 Aug; 27(4):662-665. PubMed ID: 34341959 [TBL] [Abstract][Full Text] [Related]
12. Acute motor-sensory axonal polyneuropathy variant of Guillain-Barre syndrome complicating the recovery phase of coronavirus disease 2019 infection: a case report. Haidary AM; Noor S; Hamed E; Baryali T; Rahmani S; Ahmad M; Erfani F; Azimi H; Habib HUR; Tahiri GA; Saadaat R; Ibrahimkhil AS; Esmat E; Malakzai HA J Med Case Rep; 2021 Jul; 15(1):379. PubMed ID: 34271989 [TBL] [Abstract][Full Text] [Related]
14. Is Guillain Barre syndrome truly caused by SARS-CoV-2? Finsterer J; Scorza CA; Scorza FA; Fiorini AC Am J Emerg Med; 2021 Jul; 45():649. PubMed ID: 33172743 [No Abstract] [Full Text] [Related]
15. Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report. Kang M; Seok HY J Korean Med Sci; 2022 May; 37(20):e160. PubMed ID: 35607739 [TBL] [Abstract][Full Text] [Related]
17. Physiotherapy management of a rare variant of Guillain Barre Syndrome, acute motor and sensory axonal neuropathy (AMSAN) along with COVID-19 in a 35-year-old male -a case report. Vishnuram S; Abathsagayam K; Suganthirababu P Afr Health Sci; 2022 Sep; 22(3):520-526. PubMed ID: 36910382 [TBL] [Abstract][Full Text] [Related]